Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: A review

Journal of the American Academy of Dermatology

Volumn 60, Issue 3, 2009, Pages 470-477

  Nicolaidou, Electra ^a   Antoniou, Christina ^a   Stratigos, Alexander ^a   Katsambas, Andreas D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CALCIPOTRIOL; CALCIUM CHLORIDE; CATALASE; COLECALCIFEROL DERIVATIVE; CYANOCOBALAMIN; EDETIC ACID DERIVATIVE; EMOLLIENT AGENT; ENDOTHELIN 1; FOCAL ADHESION KINASE 1; FOLIC ACID; GELATINASE A; MANGANESE EDETIC ACID BICARBONATE COMPLEX; METHOXSALEN; PLACEBO; POLYPODIUM LEUCOTOMOS EXTRACT; TACALCITOL; TACROLIMUS; THIOCTIC ACID; UNCLASSIFIED DRUG;

BLISTER; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DNA DAMAGE; DRUG EFFICACY; DRUG MECHANISM; ERYTHEMA; EXCIMER LASER; HUMAN; HYPERPIGMENTATION; IMMUNOMODULATION; KERATINOCYTE; LOW LEVEL LASER THERAPY; MELANOCYTE; MELANOMA; MONOTHERAPY; OXIDATIVE STRESS; PATHOGENESIS; PHOTOAGING; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; PUVA; REVIEW; SKIN CANCER; SKIN PIGMENTATION; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITILIGO; XEROSIS;

DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LASER THERAPY; ULTRAVIOLET THERAPY; VITILIGO;

EID: 60149109390     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.07.053     Document Type: Review

References (71)

1. Passeron T., and Ortonne J.P. Physiopathology and genetics of vitiligo. J Autoimmun 25 Suppl (2005) 63-68
2. Ongenae K., Beelaert L., van Geel N., and Naeyaert J.M. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 20 (2006) 1-8
3. Hamzavi I., Jain H., McLean D., Shapiro J., Zeng H., and Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool. Arch Dermatol 140 (2004) 677-683
4. Taieb A., and Picardo M. The definition and assessment of vitiligo: a consensus report of the vitiligo European task force. Pigment Cell Res 20 (2007) 27-35
5. Antoniou C., and Katsambas A. Guidelines for the treatment of vitiligo. Drugs 43 (1992) 490-498
6. Westerhof W., and Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 133 (1997) 1525-1528
7. Parrish J.A., and Jaenicke K.F. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76 (1981) 359-362
8. Njoo M.D., Westerhof W., Bos J.D., and Bossuyt M.M. The development of guidelines for the treatment of vitiligo. Arch Dermatol 135 (1999) 1514-1521
9. Njoo M.D., Bos J.D., and Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42 (2000) 245-253
10. Scherschun L., Kim J.J., and Lim H.W. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 44 (2001) 999-1003
11. Natta R., Somsak T., Wisuttida T., and Laor L. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 49 (2003) 473-476
12. Yashar S.S., Gielczyk R., Scherschum L., and Lim H.W. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed 19 (2003) 164-168
13. Kanwar A.J., and Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 30 (2005) 332-336
14. Kanwar A.J., Dogra S., Parsad D., and Kumar B. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int J Dermatol 44 (2005) 57-60
15. Chen G.Y., Hsu M.M., Tai H.K., Chou T.C., Tseng C.L., Chang H.Y., et al. Narrow-band UVB treatment of vitiligo in Chinese. J Dermatol 32 (2005) 793-800
16. Brazzelli V., Prestinari F., Castelo M., Bellani E., Roveda E., Barbagallo T., et al. Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatr Dermatol 22 (2005) 257-261
17. Anbar T.S., Westerhof W., Abdel-Rahman A.T., and El-Khayyat M.A. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed 22 (2006) 157-163
18. Nicolaidou E., Antoniou C., Stratigos A.J., Stefanaki C., and Katsambas A.D. Efficacy, predictors of response and long-term follow-up in vitiligo patients treated with narrow band UVB phototherapy. J Am Acad Dermatol 56 (2007) 274-278
19. Schallreuter K.U., Wood J.M., Lemke K.R., and Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study of 33 patients. Dermatology 190 (1995) 223-229
20. Patel D.C., Evans A.V., and Hawk J.L.M. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-center study. Clin Exp Dermatol 27 (2002) 641-644
21. Tjioe M., Gerritsen M.J.P., and Juhlin L. Van de Kerkhof PCM. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82 (2002) 369-372
22. Kullavanijaya P., and Lim H. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 20 (2004) 248-251
23. 311 nm vs broad-band UVB therapy in combination with topical calcipotriol vs placebo in vitiligo. Int J Dermatol 44 (2005) 736-742
24. Ada S., Sahin S., Boztepe G., Karaduman A., and Kolemen F. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photodermatol Photoimmunol Photomed 21 (2005) 79-83
25. Arca E., Tastan H.B., Erbil A.H., Sezer E., Koc E., and Kurumlu Z. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 33 (2006) 338-343
26. Goktas E.O., Aydin F., Senturk N., Canturk M.T., and Turanli A.Y. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 20 (2006) 553-557
27. Leone G., Pacifico A., Iacovelli P., Paro Vidolin A., and Picardo M. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol 31 (2006) 200-205
28. Mehrabi D., and Pandya A.G. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch Dermatol 142 (2006) 927-929
29. Fai D., Cassano N., and Vena G.A. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J Eur Acad Dermatol Venereol 21 (2007) 916-920
30. Hup-Middelkamp M.A., Bos J.D., Rius-Diaz F., Gonzalez S., and Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomus extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol 21 (2007) 942-950
31. Dell'Anna M.L., Mastrofrancesco A., Sala R., Venturini M., Ottaviani M., Vidolin A.P., et al. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 32 (2007) 631-636
32. Parsad D., Kanwar A.J., and Kumar B. Psoralen-ultraviolet A vs narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol 20 (2006) 175-177
33. El Mofty M., Mostafa W., Esmat S., Youssef R., Azzam O., Hunter N., et al. Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies. Photodermatol Photoimmunol Photomed 22 (2006) 6-11
34. Bhatnagar A., Kanwar A.J., and Parsad D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol 21 (2007) 638-642
35. Yones S.S., Palmer R.A., Garibaldinos T.M., and Hawk J.L.M. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 143 (2007) 578-584
36. Baltas E., Nagy P., Bonis B., Novak Z., Ignacz F., Szabo G., et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 144 (2001) 1266-1267
37. Spencer J.M., Nossa R., and Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 46 (2002) 727-731
38. Taneja A., Tretan M., and Taylor C.R. 308-nm Excimer laser for the treatment of localized vitiligo. Int J Dermatol 42 (2003) 658-662
39. Choi K.H., Park J.H., and Ro Y.S. Treatment of vitiligo with 308-nm xenon-chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas. J Dermatol 31 (2004) 284-292
40. Passeron T., Ostovari N., Zakaria W., Fontas E., Larrouy J.C., Lacour J.P., et al. Topical tacrolimus and the 308-nm excimer laser. Arch Dermatol 140 (2004) 1065-1069
41. Ostovari N., Passeron T., Zakaria W., Fontas E., Larouy J.C., Blot J.F., et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med 35 (2004) 152-156
42. Esposito M., Soda R., Costanzo A., and Chimenti S. Treatment of vitiligo with the 308-nm excimer laser. Clin Exp Dermatol 29 (2004) 133-137
43. Kawalek A.Z., Spencer J.M., and Phelps R.G. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 30 (2004) 130-135
44. Hong S.B., Park H.H., and Lee M.H. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci 20 (2005) 273-278
45. Hofer A., Hassan A.S., Legat F.J., Kerl H., and Wolf P. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol 20 (2006) 558-564
46. Hadi S., Tinio P., Al-Ghaithi K., Al-Qari H., Al-Helalat M., Lebwohl M., et al. Treatment of vitiligo using the 308-nm excimer laser. Photomed Laser Surg 24 (2006) 354-357
47. Greve B., Raulin C., and Fischer E. Excimer laser treatment of vitiligo-critical retrospective assessment of own results and literature overview [German]. J Dtsch Dermatol Ges 4 (2006) 32-40
48. Passeron T., and Ortonne J.P. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 24 (2006) 33-42
49. Hofer A., Hassan A.S., Legat F.J., Kerl H., and Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 152 (2005) 981-985
50. Goldinger S.M., Dummer R., Schmid P., Burg G., Seifert B., and Lauchli S. Combination of 308-nm xenon chloride laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol 21 (2007) 504-508
51. Cui J., Shen L.Y., and Wang G.C. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 97 (1991) 410-416
52. Sitek J.C., Loeb M., and Ronnevig J.R. Narrowband UVB therapy for vitiligo: does the repigmentation last?. J Eur Acad Dermatol Venereol 21 (2007) 891-896
53. Choi C.P., Kim Y.I., Lee J.W., and Lee M.H. The effect of narrowband ultraviolet B on the expression of matrix metalloproteinase-1, transforming growth factor-beta1 and type I collagen in human skin fibroblasts. Clin Exp Dermatol 32 (2007) 180-185
54. Tzung T.Y., and Runger T.M. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol 67 (1998) 647-650
55. Budiyanto A., Ueda M., Ueda T., and Ichihashi M. Formation of cyclobutane pyrimidine dimmers and 8-oxo-7,8-dihydro-2'-deoxyguanosine in mouse and organ-cultured human skin by irradiation with broadband or with narrowband UVB. Photochem Photobiol 76 (2002) 397-400
56. Weischer M., Blum A., Eberhard F., Rocken M., and Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broad band or narrow band UVB phototherapy: a first retrospective study. Acta Derm Venereol 84 (2004) 370-374
57. Hearn R.M., Dawe R.S., Kerr A., Rahim K., Ibbotson S.H., and Ferguson J. Is there a skin cancer risk with narrowband ultraviolet B phototherapy? Preliminary data from the second phase of the Dundee follow-up study. [abstract]. Br J Dermatol 155 (2006) 866-867
58. Seo S.L., and Kim I.H. Squamous cell carcinoma in a patient with generalized vitiligo. J Am Acad Dermatol 45 Suppl (2001) S227-S229
59. Ibbotson S.H., Bilsland D., Cox N.H., Dawe R.S., Diffey B., Edwards C., et al. An update and guidance on narrowband ultraviolet B phototherapy: a British photodermatology group workshop report. Br J Dermatol 151 (2004) 283-297
60. Schallreuter-Wood K.U., Pittelkow M.R., and Swanson N.N. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 288 (1996) 11-13
61. Schallreuter K.U., and Pittelkow M.R. Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 280 (1988) 137-139
62. 3 receptors in normal and psoriatic skin. J Invest Dermatol 97 (1991) 230-239
63. Zuqel U., Steinmeyer A., Giesen C., and Asadullah K. A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity. J Invest Dermatol 119 (2002) 1434-1442
64. De Rie M.A., Di Nuzzo S., Brands S., Hansen A.B., and Boss J.D. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. Br J Dermatol 142 (2000) 1160-1165
65. Youn J.I., Park B.S., Chung J.H., and Lee J.H. Photoprotective effect of calcipotriol upon skin photoreaction to UVA and UVB. Photodermatol Photoimmunol Photomed 13 (1997) 109-114
66. Hashimoto Y., Matsuoka N., Kawakami A., Tsuboi M., Nakashima T., Eguchi K., et al. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin Exp Immunol 125 (2001) 19-24
67. Lepe V., Moncada B., Castanedo-Cazares J.P., Torres-Alvarez M.B., Ortiz C.A., and Torres-Rubalcava A.B. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 139 (2003) 581-585
68. Silverberg N.B., Lin P., Travis L., Farley-Li J., Mancini A.J., Wagner A.M., et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 51 (2004) 760-766
69. Wu C.S., Yu C.L., Wu C.S., Lan C.C.E., and Yu H.S. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 13 (2004) 755-763
70. Ozawa M., Ferenczi K., Kikuchi T., Cardinale I., Austin L.M., Coven T.R., et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189 (1999) 711-718
71. Novak Z., Bonis B., Baltas E., Ocsovszki I., Ignacz F., Dobozy A., et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B 67 (2002) 32-38